drugset / Trial / NCT03442621
Relacorilant Food Effect Study in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
This is an open-label, randomized, single-dose, 3-period crossover, Williams' design, food-interaction (fasted and fed arms) study conducted in healthy subjects.
Timeline
- Start
- 2018-01-16
- Primary completion
- 2018-02-28
- Completion
- 2018-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Relacorilant | Small molecule | 350 mg | Oral |
Indications
No indication recorded.